Ledger.Open graph →
SEC Form D · filed April 2, 2019

CytoDyn Inc

Offering
$5.0M
Sold
$3.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
VANCOUVER, WA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

David F. Welch · Vancouver, WADirectorMichael D. Mulholland · Vancouver, WAExecMichael A. Klump · Vancouver, WADirectorScott A. Kelly · Vancouver, WADirectorJordan G. Naydenov · Vancouver, WADirectorNader Z. Pourhassan · Vancouver, WAExec · DirectorCarl C. Dockery · Englewood, CODirectorGregory A. Gould · Englewood, CODirectorRichard G. Pestell · Vancouver, WAExec · DirectorTerente Culver · MIAMI, FLDirectorBuligo Capital Partners Limited · Wilmington, DEExecZachary Dexter · MIAMI, FLExec · DirectorNikesh Arora · Palo Alto, CADirectorJames Wo · MIAMI, FLDirectorPaul Kotos · MIAMI, FLDirectorYuriy Gelfman · New York, NYDirectorIan Bel · New York, NYExecAlan Shvetz · New York, NYExec · DirectorMichael Rosenfeld · New York, NYDirectorLeah Brownlee · Cleveland, OHDirectorEugene Malinskiy · Cleveland, OHDirectorCarl C. Dockery · Englewood, CODirectorGregory A. Gould · Englewood, CODirectorRichard G. Pestell · Vancouver, WAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗